← brief for 2026-08-13 · Slowing decline

Immunometabolic Effects of SGLT2 Inhibitors on the Th17/Treg Axis: Mechanisms, Evidence, and Implications for Therapeutic Repurposing.

Key takeaways

SGLT2 inhibitors may influence immune cell health via metabolic reprogramming. This study used human-derived immune cells in a dish, not humans.

Who did this work

Alasbily H · Sherif FM

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42593596/